Matthews Judith M. 4
4 · Iterum Therapeutics plc · Filed Mar 15, 2022
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2022-03-11+100,000→ 128,632 total - Sale
Ordinary Shares
2022-03-14$0.38/sh−47,132$17,910→ 81,500 total - Exercise/Conversion
Restricted Share Units
2022-03-11−100,000→ 100,000 total→ Ordinary Shares (100,000 underlying)
Footnotes (3)
- [F1]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F2]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs. This sale does not represent a discretionary trade by the reporting person.
- [F3]On March 11, 2021, the reporting person was granted an award of 200,000 RSUs, 50% of which vested on March 11, 2022.